EUVIMEDEUVIMED entdecken
Crossref

Evaluation of prognostic factors of sex cord stromal tumors: a single-center experience

Belma Gözde Özdemir, Meltem Aydoğdu, Rabia Nur Sağlam, İpek Münteha Erdemli Kara, Duygu Çalık, Murat Çelik, Mustafa Gazi Uçar, Ahmet Bilgi, Çetin Çelik

Journal of Medicine and Palliative Care · 27.03.2026 · 7 (2) · 344-348

DOI: 10.47582/jompac.1887249 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicine and Palliative Care, online erschienen am 27.03.2026. Verfasst von Belma Gözde Özdemir und 8 weiteren Autor:innen. Die Arbeit nennt 21 Literaturangaben. Gefördert von: none.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Sex cord stromal tumors (SCSTs) constitute a rare subgroup of ovarian tumors, exhibiting heterogeneous clinical course and prognosis. The aim of this study is to evaluate clinicopathological factors affecting prognosis in patients with SCSTs based on single-center experience.

Methods

This retrospective study included patients diagnosed with SCSTs at Selçuk University between 2010-2025. Demographic characteristics, tumor type, tumor stage, tumor size, mitotic index, surgical approach, adjuvant therapy status, and follow-up duration were recorded. Factors affecting prognosis were analyzed in terms of overall survival and disease-free survival.

Results

A total of 94 patients with ovarian SCSTs were included in the study. Granulosa cell tumors constituted the most common histopathological subtype (n=41, 43.6%), followed by fibroma/thecoma (n=25, 26.6%) and other SCSTs (n=28, 29.8%). The mean age at diagnosis was 58.0±14.6 years. Tumor recurrence was observed in 5 patients (5.3%). At the last follow-up, 79 patients (84.0%) were alive and 15 patients (16.0%) had died. Adjuvant therapy was administered to 6 patients (6.4%), all of whom belonged to the other SCST group. Recurrence and mortality were more frequently observed in granulosa cell tumor and other SCST subgroups.

Conclusion

In SCSTs, stage, mitotic activity, and residual disease after surgery are important factors in determining prognosis. Early diagnosis and optimal cytoreduction positively influence disease-free and overall survival. Larger patient series and multicenter studies with long-term follow-up are needed.

Förderung

  • none

Zitieren

APA

Özdemir, B. G., Aydoğdu, M., Sağlam, R. N., Kara, İ. M. E., Çalık, D., Çelik, M., Uçar, M. G., Bilgi, A., & Çelik, Ç. (2026). Evaluation of prognostic factors of sex cord stromal tumors: a single-center experience. Journal of Medicine and Palliative Care, 7(2), 344-348. https://doi.org/10.47582/jompac.1887249

Vancouver

Özdemir BG, Aydoğdu M, Sağlam RN, Kara İME, Çalık D, Çelik M, et al. Evaluation of prognostic factors of sex cord stromal tumors: a single-center experience. Journal of Medicine and Palliative Care. 2026;7(2):344-348. doi:10.47582/jompac.1887249

BibTeX
@article{zdemir2026,
  author = {Özdemir, Belma Gözde and Aydoğdu, Meltem and Sağlam, Rabia Nur and Kara, İpek Münteha Erdemli and Çalık, Duygu and Çelik, Murat and Uçar, Mustafa Gazi and Bilgi, Ahmet and Çelik, Çetin},
  title = {Evaluation of prognostic factors of sex cord stromal tumors: a single-center experience},
  journal = {Journal of Medicine and Palliative Care},
  year = {2026},
  volume = {7},
  number = {2},
  pages = {344--348},
  doi = {10.47582/jompac.1887249}
}
Kostenlos starten →